CRP and pancreatic neoplasm: The serum sPD‐L1 level has been reported to be upregulated in patients with elevated markers of systemic inflammation, such as CRP, in hepatocellular carcinoma (HCC),31 gastric cancer,18 or pancreatic cancer.24